Vernon Hills, IL, United States of America

Ish K Khanna

This inventor holds 65 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Inhibitors (CPC class 5143). Top assignees: G.d. Searle & Company, Pharmacia Corporation, C. D. Searle & Co.. Active years: 1990-2008.

USPTO Granted Patents = 65

% Patents Active = 72.3

CIPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 5.4

ph-index = 16

Forward Citations = 1,119(Granted Patents)

Forward Citations (Not Self Cited) = 1,075(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Skokie, IL (US) (1990 - 1993)
Vernon Hills, IL (US) (1991 - 2007)
Libertyville, IL (US) (2002 - 2008)

Company Filing History:

46 out of 1,323

G.d. Searle & Company

patents

16 out of 220

Pharmacia Corporation

4. 2 out of 834,276

Other

patents

Years Active: 1990-2008

Loading Chart...

Areas of Expertise:

COX-2 Inhibitors

p38 Kinase

Integrin Receptor Antagonists

Prodrugs

Heterocyclo-substituted Imidazoles

Substituted Pyrazoles

Cycloalkyl Alkanoic Acids

Dihydrostilbene Derivatives

Purinylalkyl Benzamide

Heteroaryl Compounds

Thiophenolic Compounds

Glycyl Derivatives

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7420061 - Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors (2008-09-02),

2. 7220770 - Heterocyclo-substituted imidazoles for the treatment of inflammation (2007-05-22),

3. 7153959 - Substituted pyrazoles as p38 kinase inhibitors (2006-12-26),

4. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),

5. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),

6. 7071198 - Substituted pyrazoles as p38 kinase inhibitors (2006-07-04),

7. 6979686 - Substituted pyrazoles as p38 kinase inhibitors (2005-12-27),

8. 6951949 - Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation (2005-10-04),

9. 6949578 - Cycloalkyl alkanoic acids as integrin receptor antagonists (2005-09-27),

10. 6933304 - Heteroarylalkanoic acids as integrin receptor antagonists (2005-08-23),

11. 6921767 - Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives (2005-07-26),

12. 6900232 - Cycloalkyl alkanoic acids as integrin receptor antagonists (2005-05-31),

13. 6833366 - Dihydrostilbene alkanoic acid derivatives (2004-12-21),

14. 6815460 - Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors (2004-11-09),

15. 6720315 - Dihydrostilbene alkanoic acid derivatives (2004-04-13),

Title: Innovator Spotlight: Ish K Khanna

Introduction:

Ish K Khanna, a prolific inventor based in Vernon Hills, IL (US), has made remarkable contributions to the field of pharmaceuticals with his numerous patents and groundbreaking discoveries.

Latest Patents:

Khanna's latest patents showcase his expertise in pharmaceutical innovation:

1. "Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors"

2. "Heterocyclo-substituted imidazoles for the treatment of inflammation"

Career Highlights:

Khanna has an impressive portfolio of 65 patents, demonstrating his ingenuity and commitment to advancing medical treatments. He has notably worked with renowned companies such as G.D. Searle & Company and Pharmacia Corporation, where he honed his skills and contributed significantly to the industry.

Collaborations:

Throughout his career, Khanna has collaborated with esteemed professionals in the field, including Richard M Weier and Thomas Dale Penning. Their collective expertise has led to the development of groundbreaking pharmaceutical solutions and paved the way for new treatment options.

Conclusion:

Ish K Khanna's dedication to pharmaceutical innovation is evident in his extensive patent portfolio and successful collaborations. His inventive spirit and contributions to the field continue to inspire advancements in the treatment of inflammation and related disorders, leaving a lasting impact on the industry.